Across TCGA pan-cancer cohorts, TRAV40 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated TRAV40 data layer compared with 14 for mass-spec protein.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher TRAV40 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated TRAV40 expression acts as an unfavorable survival marker.

BLCA and UCEC are the cancer types where TRAV40 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	All	0.130	0.720	<.001	48	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: TRAV40 tumor-vs-normal RNA expression · all TRAV40 data types